EU Approval Granted for Pfizer Prevenar 20 Vaccine Targeting Infants and Children
Wednesday, 13 March 2024, 09:37
Pfizer Prevenar 20 Vaccine Receives EU Approval for Infants and Children
The European Commission has granted marketing authorization for Pfizer's Prevenar 20, a vaccine designed to protect infants and children against pneumococcal diseases. This approval marks a significant milestone in pediatric healthcare, offering enhanced protection and preventing potential illnesses in this demographic.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.